vimarsana.com

Thomas Voit News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Antisense Therapeutics (ASX:ANP) receives first approval for phase two DMD clinical trial

Researchers combine motion capture and AI to treat movement disorders

UK researchers have shown that AI can be combined with motion capture suits to create a "faster, cheaper" way of treating movement disorders.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.